Chesapeake IRB launches CIRBI in Canada
Cloud-based platform integrates operations in the United States and Canada.
After joining forces in April of this year, Chesapeake IRB and IRB Services, both North American leaders in providing central ethical review services, began making plans to integrate submission processes in the United States and Canada utilizing a common, powerful, proven, electronic platform, CIRBI.
We are pleased to announce that the integration is now complete.
Center for IRB Intelligence (CIRBI™)
Chesapeake IRB's revolutionary platform, the Center for IRB Intelligence (CIRBI), provides cloud-based access to an entire ethics review project. The fully integrated system unifies all Chesapeake IRB and IRB Services functions under one easy-to-use platform.
CIRBI, which already has thousands of sponsors and investigators on board, provides revolutionary capabilities for accelerating cycle time and proactive project management. It is a powerful, elegant, efficient and trusted tool.
Progressive, Creative, Transformative
Jeff Wendel, President of Chesapeake IRB, said the decision to offer CIRBI in the US and Canada represents the progressive, creative approach to problem-solving that characterizes both companies.
"Our decision to integrate CIRBI was driven by our desire to provide North American clients with the benefit of one-click access to study information."
Jack Corman, Founder and Managing Director of IRB Services, calls CIRBI a truly transformative study management tool.
"CIRBI is the only electronic clinical project management platform that's genuinely seamless - gives both clients and sites a fully transparent, uniquely empowering experience to drive efficiencies as never before."
About Chesapeake IRB
Chesapeake IRB has been providing independent IRB services for major pharmaceutical companies, universities, individual researchers, academic medical centers, and community hospitals since 1993.
Chesapeake IRB earned AAHRPP accreditation in 2004 and was accredited for a third time in June 2010.
Chesapeake IRB offers a unique 21 CFR Part 11 compliant, electronic IRB platform (CIRBI) which streamlines protocol submissions and decreases investigator review turnaround times resulting in faster subject enrollments.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
